Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
4.310
-1.060 (-19.74%)
At close: Apr 10, 2026, 4:00 PM EDT
4.389
+0.079 (1.83%)
After-hours: Apr 10, 2026, 7:04 PM EDT
Harvard Bioscience Analyst Ratings
Total Analysts
3
Consensus Rating
Buy
Price Target
$18.00
Upside
+317.63%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Buy Maintains $0.6 → $6 | Buy | Maintains | $0.6 → $6 | +39.21% | Mar 16, 2026 |
| Benchmark | Benchmark | Buy Maintains $2 → $0.6 | Buy | Maintains | $2 → $0.6 | -86.08% | Mar 13, 2026 |
| Benchmark | Benchmark | Buy Maintains $30 → $20 | Buy | Maintains | $30 → $20 | +364.04% | Sep 10, 2025 |
| Benchmark | Benchmark | Buy Maintains $45 → $30 | Buy | Maintains | $45 → $30 | +596.06% | May 13, 2025 |
| Keybanc | Keybanc | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Apr 9, 2025 |
| Benchmark | Benchmark | Buy Maintains $55 → $45 | Buy | Maintains | $55 → $45 | +944.08% | Mar 24, 2025 |
| Benchmark | Benchmark | Buy Reiterates $70 | Buy | Reiterates | $70 | +1,524.13% | Jun 22, 2023 |
| Benchmark | Benchmark | Strong Buy Maintains $40 → $70 | Strong Buy | Maintains | $40 → $70 | +1,524.13% | Apr 26, 2023 |
| Keybanc | Keybanc | Buy Maintains $50 → $70 | Buy | Maintains | $50 → $70 | +1,524.13% | Apr 26, 2023 |
| Benchmark | Benchmark | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +828.07% | Mar 10, 2023 |
| Keybanc | Keybanc | Buy Maintains $70 → $50 | Buy | Maintains | $70 → $50 | +1,060.09% | Nov 9, 2022 |
| Keybanc | Keybanc | Buy Maintains $100 → $70 | Buy | Maintains | $100 → $70 | +1,524.13% | Aug 5, 2022 |
| Keybanc | Keybanc | Buy Initiates $60 | Buy | Initiates | $60 | +1,292.11% | Nov 10, 2020 |
| Benchmark | Benchmark | Buy Maintains $35 → $40 | Buy | Maintains | $35 → $40 | +828.07% | Feb 27, 2020 |
| Benchmark | Benchmark | Strong Buy Initiates $80 | Strong Buy | Initiates | $80 | +1,756.15% | Jul 28, 2015 |